Correction: Hiroshi Sugano et al. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10,... by Hiroshi Sugano, Yoshihiro Shirai, Takashi Horiuchi, Nobuhiro Saito, Yohta Shimada, Ken Eto, Tadashi Uwagawa, Toya Ohashi, Katsuhiko Yanaga

Get full text

Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells by Hiroshi Sugano, Yoshihiro Shirai, Takashi Horiuchi, Nobuhiro Saito, Yohta Shimada, Ken Eto, Tadashi Uwagawa, Toya Ohashi, Katsuhiko Yanaga

Get full text

Thrombomodulin expression impacts the recurrence and long‐term survival in pancreatic cancer by Hiroshi Sugano, Yoshihiro Shirai, Shun Sato, Shigeharu Hamatani, Ryoga Hamura, Tomohiko Taniai, Takashi Horiuchi, Takeshi Gocho, Ken Eto, Toru Ikegami

Get full text

Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells. by Naoki Takada, Hiroshi Sugano, Yoshihiro Shirai, Nobuhiro Saito, Ryoga Hamura, Tomohiko Taniai, Tadashi Uwagawa, Katsuhiko Yanaga, Toru Ikegami, Toya Ohashi, Ken Eto

Get full text

Evaluation of the Outcome of Local Surgery for Stomal Prolapse by Makoto Kosuge, Masahisa Ohkuma, Muneyuki Koyama, Yasunobu Kobayashi, Takafumi Nakano, Yasuhiro Takano, Yuya Shimoyama, Naoki Takada, Tomotaka Kumamoto, Yuta Imaizumi, Hiroshi Sugano, Seiichiro Eto, Yasuhiro Takeda, Saori Yatabe, Ken Eto

Get full text